Prognostic Value of 18F-FDG PET/CT in Neoadjuvant PD-1 Inhibitor-treated NSCLC: A Five-year Follow-up Study. Tao X, Zhang Q, Li N, Wang S, et al. Clin Nucl Med 2025;50:577-587.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Tao X, Zhang Q, Li N, Wang S, et al. Prognostic Value of 18F-FDG PET/CT in Neoadjuvant PD-1 Inhibitor-treated NSCLC: A Five-year Follow-up Study. Clin Nucl Med 2025;50:577-587.
PMID: 40462321